Showing results (171-180 of 378) with videos related to

Sort By:
Pageof 38
Blood|August 1, 1994
High-dose therapy for refractory multiple myeloma: improved prognosis with better supportive care and double transplantsD H Vesole, B Barlogie, S Jagannath, et al.
Urology|June 28, 2000
Cushing syndrome as the presenting feature of metastatic Leydig cell tumor of the testisC Papadimitris, M Alevizaki, D Pantazopoulos, et al.
European Urology|January 1, 1984
Genetic markers in carcinoma of the prostateM A Dimopoulos, A Germenis, P Savides, et al.
Leukemia & Lymphoma|March 14, 1998
Very late relapse of Hodgkin's disease after 24 years of complete remissionM A Dimopoulos, E Kostis, A Anagnostopoulos, et al.
Presse Medicale (Paris, France : 1983)|March 19, 1983
[Genetic markers in benign hypertrophy of the prostate]A Germenis, P Savides, M A Dimopoulos, et al.
Blood|August 1, 1988
Correlated flow cytometric analysis of H-ras p21 and nuclear DNA in multiple myelomaH Tsuchiya, J Epstein, P Selvanayagam, et al.
International Journal of Radiation Oncology, Biology, Physics|August 27, 1998
Solitary bone plasmacytoma: outcome and prognostic factors following radiotherapyR H Liebross, C S Ha, J D Cox, et al.
Bone Marrow Transplantation|June 30, 1998
Long-term follow-up after high-dose therapy for high-risk multiple myelomaB Barlogie, S Jagannath, S Naucke, et al.
Gynecologic Oncology|March 1, 1997
Primary ovarian non-Hodgkin's lymphoma: outcome after treatment with combination chemotherapyM A Dimopoulos, D Daliani, W Pugh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 6, 2000
Molecular aspects of multiple myelomaN G Kastrinakis, V G Gorgoulis, P G Foukas, et al.
Pageof 38